Israel is engaged in two race chases against the Covid-19.
The first aims to vaccinate its entire population in order to achieve a collective immunity rate.
It is energized thanks to the agreements made very early on with laboratories and the mobilization of health insurance funds which crisscross this country of approximately 8 million inhabitants.
Unique in the world, the experiment makes it possible to openly collect data on the consequences of vaccination.
It is also the subject of a protocol between the Israeli state and the firm Pfizer.
The first results are very encouraging.
A study of 135,000 people who were vaccinated shows that a tiny percentage of those protected fell ill (around 0.05%).
The first bite causes an antiviral reaction which does not take on its real immunity until after the booster several weeks later.
Of the 20 vaccinated patients identified, none developed a severe form of the disease, and
This article is for subscribers only.
You have 72% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
I ENJOY IT
Already subscribed?
Log in